Vector Science unveils peptide-matrix microneedle platform for transdermal delivery

The wire

1. 01Vector Science and Therapeutics introduced an investigational dissolving microneedle platform in which the peptide serves as the predominant structural material, delivered via static patches or a handheld roller with replaceable cartridges.
2. 02Needle-free routes for peptides matter to clinicians and operators facing adherence and administration-cost problems, since injections remain standard for most peptide and large-molecule therapeutics.
3. 03The platform is preclinical and unvalidated; the company says stated benefits remain subject to testing, and its 15 patent applications covering transdermal and lyophilized peptide delivery are still pending.

From the source

Vector Science and Therapeutics Corp. Introduces Peptide-Matrix Microneedle Technology for Targeted Transdermal Delivery of Peptides

Investigational dissolving microneedle platform uses the therapeutic peptide as the structural material of the needle itself, with an initial focus on sports medicine and regenerative medicine